78 related articles for article (PubMed ID: 38312120)
1. Multicentre, cross-sectional surveillance of Helicobacter pylori prevalence and antibiotic resistance to clarithromycin and levofloxacin in urban China using the string test coupled with quantitative PCR.
Wang L; Li Z; Tay CY; Marshall BJ; Gu B;
Lancet Microbe; 2024 Jun; 5(6):e512-e513. PubMed ID: 38437848
[No Abstract] [Full Text] [Related]
2. Testing for
Schuetz AN; Theel ES; Cole NC; Rothstein TE; Gordy GG; Patel R
J Clin Microbiol; 2024 Feb; 62(2):e0073223. PubMed ID: 38193664
[TBL] [Abstract][Full Text] [Related]
3. The effects and mechanisms of natural products on
Deng R; Chen X; Zhao S; Zhang Q; Shi Y
Front Cell Infect Microbiol; 2024; 14():1360852. PubMed ID: 38481665
[No Abstract] [Full Text] [Related]
4. Empirical or susceptibility-guided treatment for
Gisbert JP
Therap Adv Gastroenterol; 2020; 13():1756284820968736. PubMed ID: 33240392
[TBL] [Abstract][Full Text] [Related]
5. Predictors of Successful First-Line
Khadim S; Muhammad IN; Alam T; Usman S; Rehman H; Haider S
Antibiotics (Basel); 2024 Feb; 13(3):. PubMed ID: 38534646
[TBL] [Abstract][Full Text] [Related]
6. Sodium sulfite-driven Helicobacter pylori eradication: Unraveling oxygen dynamics through multi-omics investigation.
Huang TT; Liu YN; Huang JX; Yan PP; Wang JJ; Cao YX; Cao L
Biochem Pharmacol; 2024 Apr; 222():116055. PubMed ID: 38354959
[TBL] [Abstract][Full Text] [Related]
7. Best Practices for
Graham DY
Gastroenterol Hepatol (N Y); 2024 Mar; 20(3):159-168. PubMed ID: 38680170
[TBL] [Abstract][Full Text] [Related]
8.
Losurdo G; Mezzapesa M; Ditonno I; Piazzolla M; Pricci M; Girardi B; Celiberto F; Galeano G; Riezzo G; Russo F; Iannone A; Ierardi E; Di Leo A
Antibiotics (Basel); 2024 Apr; 13(4):. PubMed ID: 38667013
[No Abstract] [Full Text] [Related]
9. Molecular testing-guided therapy versus susceptibility testing-guided therapy in first-line and third-line Helicobacter pylori eradication: two multicentre, open-label, randomised controlled, non-inferiority trials.
Chen MJ; Chen PY; Fang YJ; Bair MJ; Chen CC; Chen CC; Yang TH; Lee JY; Yu CC; Kuo CC; Chiu MC; Chou CK; Chen CY; Hu WH; Tsai MH; Hsu YC; Shun CT; Luo JC; Lin JT; El-Omar EM; Wu MS; Liou JM;
Lancet Gastroenterol Hepatol; 2023 Jul; 8(7):623-634. PubMed ID: 37178702
[TBL] [Abstract][Full Text] [Related]
10. Novel and Effective Therapeutic Regimens for
Hu Y; Zhu Y; Lu NH
Front Cell Infect Microbiol; 2017; 7():168. PubMed ID: 28529929
[No Abstract] [Full Text] [Related]
11. Helicobacter pylori: A Review of Current Diagnostic and Management Strategies.
Guevara B; Cogdill AG
Dig Dis Sci; 2020 Jul; 65(7):1917-1931. PubMed ID: 32170476
[TBL] [Abstract][Full Text] [Related]
12. Success of susceptibility-guided eradication of
Wang YM; Chen MY; Chen J; Zhang XH; Feng Y; Han YX; Li YL
World J Gastroenterol; 2024 Jan; 30(2):184-195. PubMed ID: 38312120
[TBL] [Abstract][Full Text] [Related]
13. Quantitative PCR of string-test collected gastric material: A feasible approach to detect Helicobacter pylori and its resistance against clarithromycin and levofloxacin for susceptibility-guided therapy.
Han X; Yu X; Gao X; Wang X; Tay CY; Wei X; Lai B; Marshall BJ; Zhang X; Chua EG
Helicobacter; 2023 Aug; 28(4):e12985. PubMed ID: 37066609
[TBL] [Abstract][Full Text] [Related]
14. Tailored therapy guided by genotypic resistance of clarithromycin and levofloxacin detected by polymerase chain reaction in the first-line treatment of Helicobacter pylori infection.
Li CL; Zhou K; Zhang YX; Suo BJ; Tian XL; Zhang YX; Ren XL; Shi YY; Zhou LY; Song ZQ
J Dig Dis; 2024 Jan; 25(1):36-43. PubMed ID: 38323705
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
